Xtant Medical (XTNT) Stock Analysis & Price (Updated Oct 16, 2026, 4:00 PM ET)
Updated Oct 16, 2026, 4:00 PM ET
- Closed at $0.29, -4.43% vs the prior close of $0.30.
- Volume 97.52K shares, 0.0x its 50-day average (light).
- No new SEC filings since the prior session.
- No new insider buys or sales reported since the prior session.
XTNT slides 4.4% to $0.29, a 52-week low, 5 down days in a row. Closed at $0.29, -4.43% vs the prior close of $0.30. Day range $0.28–$0.31, opened at $0.30.
XTNT daily analysis — what happened
A plain-English, data-only note written after every US trading day. Newest first; older days stay archived below.
Oct 16, 2026 — XTNT slides 4.4% to $0.29, a 52-week low, 5 down days in a row
- Closed at $0.29, -4.43% vs the prior close of $0.30. Day range $0.28–$0.31, opened at $0.30.
- Volume was 97.52K shares, 0.0x its 50-day average of 2.14M — lighter than usual.
- Price is -16.7% vs its 50-day average ($0.34) and -40.6% vs its 200-day average ($0.48).
- 52-week range $0.27–$0.95; today's close sits at 2% of that range, 69.8% below the 52-week high.
- That makes 5 straight losses.
Oct 15, 2026 — XTNT slides 6.2% to $0.30, a 52-week low, 4 down days in a row
- Closed at $0.30, -6.25% vs the prior close of $0.32. Day range $0.30–$0.33, opened at $0.31.
- Volume was 124.30K shares, 0.1x its 50-day average of 2.14M — lighter than usual.
- Price is -13.6% vs its 50-day average ($0.35) and -38.1% vs its 200-day average ($0.48).
- 52-week range $0.27–$0.95; today's close sits at 4% of that range, 68.4% below the 52-week high.
- That makes 4 straight losses.
Oct 14, 2026 — XTNT ends flat (+0.0%) to $0.32, 3 down days in a row
- Closed at $0.32, +0.00% vs the prior close of $0.32. Day range $0.31–$0.32, opened at $0.32.
- Volume was 85.90K shares, 0.0x its 50-day average of 2.14M — lighter than usual.
- Price is -8.6% vs its 50-day average ($0.35) and -34.3% vs its 200-day average ($0.49).
- 52-week range $0.27–$0.95; today's close sits at 7% of that range, 66.3% below the 52-week high.
- That makes 3 straight losses.
Oct 13, 2026 — XTNT slides 3.0% to $0.32
- Closed at $0.32, -3.03% vs the prior close of $0.33. Day range $0.32–$0.33, opened at $0.32.
- Volume was 38.40K shares, 0.0x its 50-day average of 2.14M — lighter than usual.
- Price is -9.2% vs its 50-day average ($0.35) and -34.6% vs its 200-day average ($0.49).
- 52-week range $0.27–$0.95; today's close sits at 7% of that range, 66.3% below the 52-week high.
Oct 12, 2026 — XTNT ends flat (+0.0%) to $0.33
- Closed at $0.33, +0.00% vs the prior close of $0.33. Day range $0.32–$0.33, opened at $0.32.
- Volume was 50.50K shares, 0.0x its 50-day average of 2.14M — lighter than usual.
- Price is -7.0% vs its 50-day average ($0.35) and -32.9% vs its 200-day average ($0.49).
- 52-week range $0.27–$0.95; today's close sits at 9% of that range, 65.3% below the 52-week high.
Oct 9, 2026 — XTNT jumps 3.1% to $0.33
- Closed at $0.33, +3.13% vs the prior close of $0.32. Day range $0.32–$0.33, opened at $0.33.
- Volume was 79.50K shares, 0.0x its 50-day average of 2.14M — lighter than usual.
- Price is -7.5% vs its 50-day average ($0.36) and -33.2% vs its 200-day average ($0.49).
- 52-week range $0.27–$0.95; today's close sits at 9% of that range, 65.3% below the 52-week high.
Oct 8, 2026 — XTNT ends flat (+0.0%) to $0.32, 11 down days in a row
- Closed at $0.32, +0.00% vs the prior close of $0.32. Day range $0.32–$0.33, opened at $0.32.
- Volume was 57.30K shares, 0.0x its 50-day average of 2.14M — lighter than usual.
- Price is -10.8% vs its 50-day average ($0.36) and -35.6% vs its 200-day average ($0.50).
- 52-week range $0.27–$0.95; today's close sits at 7% of that range, 66.3% below the 52-week high.
- That makes 11 straight losses.
Oct 7, 2026 — XTNT ends flat (+0.0%) to $0.32, 10 down days in a row
- Closed at $0.32, +0.00% vs the prior close of $0.32. Day range $0.32–$0.33, opened at $0.32.
- Volume was 86.50K shares, 0.0x its 50-day average of 2.14M — lighter than usual.
- Price is -11.4% vs its 50-day average ($0.36) and -35.9% vs its 200-day average ($0.50).
- 52-week range $0.27–$0.95; today's close sits at 7% of that range, 66.3% below the 52-week high.
- That makes 10 straight losses.
Oct 6, 2026 — XTNT slides 3.0% to $0.32, 9 down days in a row
- Closed at $0.32, -3.03% vs the prior close of $0.33. Day range $0.32–$0.34, opened at $0.34.
- Volume was 201.70K shares, 0.1x its 50-day average of 2.14M — lighter than usual.
- Price is -11.9% vs its 50-day average ($0.36) and -36.1% vs its 200-day average ($0.50).
- 52-week range $0.27–$0.95; today's close sits at 7% of that range, 66.3% below the 52-week high.
- That makes 9 straight losses.
Oct 5, 2026 — XTNT dips 2.9% to $0.33, 8 down days in a row
- Closed at $0.33, -2.94% vs the prior close of $0.34. Day range $0.33–$0.37, opened at $0.35.
- Volume was 180.40K shares, 0.1x its 50-day average of 2.13M — lighter than usual.
- Price is -9.7% vs its 50-day average ($0.37) and -34.4% vs its 200-day average ($0.50).
- 52-week range $0.27–$0.95; today's close sits at 9% of that range, 65.3% below the 52-week high.
- That makes 8 straight losses.
Oct 2, 2026 — XTNT dips 2.9% to $0.34, 7 down days in a row
- Closed at $0.34, -2.86% vs the prior close of $0.35. Day range $0.34–$0.36, opened at $0.35.
- Volume was 72.00K shares, 0.0x its 50-day average of 2.13M — lighter than usual.
- Price is -7.5% vs its 50-day average ($0.37) and -32.7% vs its 200-day average ($0.51).
- 52-week range $0.27–$0.95; today's close sits at 10% of that range, 64.2% below the 52-week high.
- That makes 7 straight losses.
XTNT latest news & SEC filings
Every SEC filing by or about XTNT in the last 120 days, explained in plain English. Updated daily, with a same-day refresh for new filings.
Aug 18, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Aug 18, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Aug 18, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Aug 18, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Aug 18, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Aug 18, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Aug 11, 2026 · Form 10-Q — Quarterly report
Quarterly report (unaudited financial statements for the quarter)
Quarter ended Jun 30, 2026:
- Revenue: $23.03M (prior year $35.41M) (-35.0% vs Jun 30, 2025)
- Net income: -$9.41M (prior year $3.55M) (loss widened vs Jun 30, 2025)
- Diluted EPS: -$0.07 (prior year $0.02) (loss widened vs Jun 30, 2025)
Aug 11, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 2.02 — Reported results of operations (earnings release).
This is a results-day filing: the earnings press release is attached as an exhibit.
Aug 7, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 5.07 — Reported shareholder vote results.
Jun 23, 2026 · Form ARS — Annual report to shareholders
Annual report to shareholders
Jun 23, 2026 · Form DEFA14A — Additional proxy materials
Additional proxy materials
Jun 23, 2026 · Form DEF 14A — Proxy statement
Proxy statement — agenda for the shareholder meeting (board elections, executive pay, votes)
Things to know before you trade XTNT
- Last results release: Aug 11, 2026 (8-K Item 2.02). Previous ones: May 13, 2026, Mar 31, 2026, Nov 10, 2025. Based on that rhythm, the next report is likely around Nov 10, 2026 — an estimate, not a confirmed date.
- How much it moves: over the last 20 sessions the average daily move was 2.57% (largest 8.6%).
- Liquidity: about 153.99K shares (≈$44.15K) trade per day on average. Thin volume can mean wider bid/ask spreads.
- 52-week position: $0.29 vs a range of $0.27–$0.95 (2% of the range).
- Dividends: no cash dividends in the last 2 years.
- Splits: none in the last 2 years.
- Insider trades (Form 4, last 12 months, recent 25 shown): 0 open-market buys, 0 sales.
- Latest filings: 10-Q Aug 11, 2026; 8-K Aug 11, 2026; 8-K Aug 7, 2026.
- Share count: 140.29M shares outstanding (Aug 7, 2026), +7.7% vs a year earlier — notable dilution.
- Listing: NYSE · industry: Surgical & Medical Instruments & Apparatus.
XTNT market data (last 20 sessions)
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 16, 2026 | 0.30 | 0.31 | 0.28 | 0.29 | 97.52K |
| Oct 15, 2026 | 0.31 | 0.33 | 0.30 | 0.30 | 124.30K |
| Oct 14, 2026 | 0.32 | 0.32 | 0.31 | 0.32 | 85.90K |
| Oct 13, 2026 | 0.32 | 0.33 | 0.32 | 0.32 | 38.40K |
| Oct 12, 2026 | 0.32 | 0.33 | 0.32 | 0.33 | 50.50K |
| Oct 9, 2026 | 0.33 | 0.33 | 0.32 | 0.33 | 79.50K |
| Oct 8, 2026 | 0.32 | 0.33 | 0.32 | 0.32 | 57.30K |
| Oct 7, 2026 | 0.32 | 0.33 | 0.32 | 0.32 | 86.50K |
| Oct 6, 2026 | 0.34 | 0.34 | 0.32 | 0.32 | 201.70K |
| Oct 5, 2026 | 0.35 | 0.37 | 0.33 | 0.33 | 180.40K |
| Oct 2, 2026 | 0.35 | 0.36 | 0.34 | 0.34 | 72.00K |
| Oct 1, 2026 | 0.36 | 0.37 | 0.35 | 0.35 | 36.80K |
| Sep 30, 2026 | 0.37 | 0.38 | 0.35 | 0.36 | 355.40K |
| Sep 29, 2026 | 0.36 | 0.37 | 0.35 | 0.36 | 187.70K |
| Sep 28, 2026 | 0.33 | 0.39 | 0.33 | 0.36 | 230.20K |
| Sep 25, 2026 | 0.38 | 0.38 | 0.36 | 0.38 | 166.60K |
| Sep 24, 2026 | 0.37 | 0.38 | 0.36 | 0.38 | 72.80K |
| Sep 23, 2026 | 0.36 | 0.38 | 0.35 | 0.38 | 169.80K |
| Sep 22, 2026 | 0.35 | 0.38 | 0.34 | 0.35 | 467.40K |
| Sep 21, 2026 | 0.33 | 0.36 | 0.32 | 0.34 | 319.00K |
About Xtant Medical
Xtant Medical (XTNT) is listed on the NYSE and classified by the SEC under “Surgical & Medical Instruments & Apparatus”. Its business address is in BELGRADE, MT. State of incorporation: DE. Fiscal year ends December 31. SEC CIK 1453593.
XTNT board of directors & executives
From SEC Form 3/4/5 insider filings made in the last 12 months (date = latest filing).
Directors
| Name | Role | Latest filing |
|---|---|---|
| John K Bakewell | Director | Aug 18, 2026 |
| Jonn R. Beeson | Director | Aug 18, 2026 |
| Sean E Browne | President and CEO | Aug 18, 2026 |
| Abhinav Jain | Director | Aug 18, 2026 |
| Tyler Lipschultz | Director | Aug 18, 2026 |
| Stavros G. Vizirgianakis | Director | Aug 18, 2026 |
Executive officers
| Name | Title | Latest filing |
|---|---|---|
| Sean E Browne | President and CEO | Aug 18, 2026 |
| Scott C Neils | CFO and Assistant Secretary | Aug 18, 2026 |
| Mark A. Schallenberger | Chief Operating Officer | Aug 18, 2026 |
Recent insider buys & sales
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| No open-market insider buys or sales reported in the last 12 months. | ||||
XTNT financials (annual, from XBRL filings)
| Fiscal year end | Revenue | Net income | Diluted EPS | Operating cash flow |
|---|---|---|---|---|
| Dec 31, 2025 | $133.93M | $4.97M | 0.03 | $12.55M |
| Dec 31, 2024 | $117.27M | $-16.45M | -0.12 | $-11.90M |
| Dec 31, 2023 | $91.30M | $660.00K | 0.01 | $-9.52M |
| Dec 31, 2022 | $57.97M | $-8.48M | -0.09 | $-5.34M |
| Dec 31, 2021 | $55.26M | $-4.85M | -0.06 | $439.00K |
Latest balance sheet: total assets $79.67M, total liabilities $39.65M, cash $9.87M (as of Jun 30, 2026).
XTNT earnings / results-day log
| Date | Filing | Close that day |
|---|---|---|
| Aug 11, 2026 | 8-K Item 2.02 (results) | $0.32 |
| May 13, 2026 | 8-K Item 2.02 (results) | $0.48 |
| Mar 31, 2026 | 8-K Item 2.02 (results) | $0.56 |
| Nov 10, 2025 | 8-K Item 2.02 (results) | $0.76 |
| Aug 12, 2025 | 8-K Item 2.02 (results) | $0.67 |
| May 12, 2025 | 8-K Item 2.02 (results) | $0.52 |
| Apr 16, 2025 | 8-K Item 2.02 (results) | $0.40 |
| Mar 6, 2025 | 8-K Item 2.02 (results) | $0.48 |
| Nov 12, 2024 | 8-K Item 2.02 (results) | $0.54 |
| Aug 8, 2024 | 8-K Item 2.02 (results) | — |
| May 15, 2024 | 8-K Item 2.02 (results) | — |
| Apr 1, 2024 | 8-K Item 2.02 (results) | — |
Related stocks · Surgical & Medical Instruments & Apparatus
Boston Scientific (BSX)Stryker (SYK)3M (MMM)Dexcom (DXCM)Medline (MDLN)Becton Dickinson (BDX)MiniMed (MMED)Resmed (RMD)Insulet (PODD)West Pharmaceutical Services (WST)
Popular today
Spdr S&P 500 Etf (SPY)Micron Technology (MU)Nvidia (NVDA)Meta Platforms (META)Sandisk (SNDK)AMD (AMD)Space Exploration Technologies (SPCX)Tesla (TSLA)Apple (AAPL)Intel (INTC)Microsoft (MSFT)Amazon (AMZN)
More on XTNT
Information only, not investment advice. BuyMeWhiskey is not a registered investment adviser or broker-dealer; nothing here is a recommendation to buy, sell or hold any security, and there are no price targets. Data comes from SEC EDGAR filings and public end-of-day market data and may be delayed or contain errors. Verify with the company's filings before making decisions. Prices: end-of-day data as of Oct 16, 2026, 4:00 PM ET. Filings: SEC EDGAR. Updated after every US trading day.